Chemotherapy-induced neutropenia and emerging agents for prevention and treatment: A review

被引：25
作者：
Blayney, Douglas W. [1 ,3 ]
Schwartzberg, Lee [2 ]
机构：
[1] Stanford Canc Inst, Stanford, CA 75216 USA
[2] Univ Nevada, Renown Inst Canc, Reno, NV USA
[3] 875 Blake Wilbur Dr,Room CC-2219,M-C 6576, Stanford, CA 94305 USA
来源：
CANCER TREATMENT REVIEWS | 2022年 / 109卷
关键词：
Chemotherapy -induced neutropenia; G-CSF; Trilaciclib; Plinablin; Efbemalenograstim alpha; Eflapegrastim; INDUCED FEBRILE NEUTROPENIA; COLONY-STIMULATING FACTOR; RELATIVE DOSE INTENSITY; PER-CYCLE PEGFILGRASTIM; US CLINICAL-PRACTICE; BREAST-CANCER; PRIMARY PROPHYLAXIS; PLINABULIN PLIN; BIOSIMILAR FILGRASTIM; RECEIVING CHOP;
D O I：
10.1016/j.ctrv.2022.102427
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页数：10
相关论文
共 50 条
  • [41] Meta-analysis and indirect treatment comparison of lipegfilgrastim with pegfilgrastim and filgrastim for the reduction of chemotherapy-induced neutropenia-related events
    Bond, T. Christopher
    Szabo, Erika
    Gabriel, Susan
    Klastersky, Jean
    Tomey, Omar
    Mueller, Udo
    Schwartzberg, Lee
    Tang, Boxiong
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2018, 24 (06) : 412 - 423
  • [42] Lipegfilgrastim for prophylaxis of chemotherapy-induced neutropenia in Dutch patients
    Timmer-Bonte, J. N. H.
    Ouwerkerk, J.
    Faber, L. M.
    Kerkhofs, L. G. M.
    Laterveer, L.
    ten Oever, D.
    van Rees, B. P.
    van der Linden, P. W.
    NETHERLANDS JOURNAL OF MEDICINE, 2020, 78 (05) : 270 - 276
  • [43] Chemotherapy-induced neutropenia among breast Cancer patients in a tertiary care hospital: Risk and consequences
    Joseph, Anu
    Joshua, Julie Mariam
    Mathews, Santhosh M.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2023, 29 (03) : 529 - 533
  • [44] Lipegfilgrastim in the management of chemotherapy-induced neutropenia of cancer patients
    Guariglia, Roberto
    Martorelli, Maria Carmen
    Lerose, Rosa
    Telesca, Donatella
    Milella, Maria Rita
    Musto, Pellegrino
    BIOLOGICS-TARGETS & THERAPY, 2016, 10 : 1 - 8
  • [45] The Patient Care Monitor-Neutropenia Index: Development, Reliability, and Validity of a Measure for Chemotherapy-Induced Neutropenia
    Olsen, James P.
    Baldwin, Scott
    Houts, Arthur C.
    ONCOLOGY NURSING FORUM, 2011, 38 (03) : 360 - 367
  • [46] Prevention of chemotherapy-induced ovarian damage
    Roness, Hadassa
    Kashi, Oren
    Meirow, Dror
    FERTILITY AND STERILITY, 2016, 105 (01) : 20 - 29
  • [47] Chemotherapy-induced neutropenia/febrile neutropenia prophylaxis with biosimilar filgrastim in solid tumors versus hematological malignancies: MONITOR-GCSF study
    Ludwig, Heinz
    Bokemeyer, Carsten
    Aapro, Matti
    Boccadoro, Mario
    Gascon, Pere
    Denhaerynck, Kris
    Krendyukov, Andriy
    Abraham, Ivo
    MacDonald, Karen
    FUTURE ONCOLOGY, 2019, 15 (08) : 897 - 908
  • [48] Romiplostim in chemotherapy-induced thrombocytopenia: A review of the literature
    Soff, Gerald A.
    Al-Samkari, Hanny
    Leader, Avi
    Eisen, Melissa
    Saad, Hossam
    CANCER MEDICINE, 2024, 13 (15):
  • [49] Safety profile of G-CSF in chemotherapy-induced neutropenia: A prospective observational study in Eastern India
    Deb, Uttiya
    Mukhopadhyay, Sandip
    Banerjee, Sanatan
    Biswas, Supreeti
    INDIAN JOURNAL OF CANCER, 2022, 59 (04) : 493 - 498
  • [50] TLR2 agonism reverses chemotherapy-induced neutropenia in Macaca fascicularis
    Laping, Nicholas J.
    DeMartino, Michael P.
    Cottom, Joshua E.
    Axten, Jeffrey M.
    Emery, John G.
    Guss, Jeffrey H.
    Burman, Miriam
    Foley, James J.
    Cheung, Mui
    Oliff, Allen
    Kumar, Sanjay
    BLOOD ADVANCES, 2017, 1 (26) : 2553 - 2562
12345